Vir Biotechnology Inc (NASDAQ: VIR) is -30.93% lower on its value in year-to-date trading and has touched a low of $4.32 and a high of $14.45 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The VIR stock was last observed hovering at around $4.94 in the last trading session, with the day’s gains setting it 0.13%.
Currently trading at $5.07, the stock is 2.27% and -9.61% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.72 million and changing 2.63% at the moment leaves the stock -34.00% off its SMA200. VIR registered -49.80% loss for a year compared to 6-month loss of -33.46%. The firm has a 50-day simple moving average (SMA 50) of $5.6452 and a 200-day simple moving average (SMA200) of $7.69915.
The stock witnessed a -16.61% gain in the last 1 month and extending the period to 3 months gives it a -35.98%, and is 12.67% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.56% over the week and 4.89% over the month.
Vir Biotechnology Inc (VIR) has around 408 employees, a market worth around $700.87M and $20.86M in sales. Profit margin for the company is -2769.04%. Distance from 52-week low is 17.36% and -64.91% from its 52-week high. The company has generated returns on investments over the last 12 months (-51.03%).
The EPS is expected to grow by 16.37% this year.
Vir Biotechnology Inc (VIR) Top Institutional Holders
330.0 institutions hold shares in Vir Biotechnology Inc (VIR), with institutional investors hold 102.31% of the company’s shares. The shares outstanding are 138.06M, and float is at 89.14M with Short Float at 12.28%. Institutions hold 79.13% of the Float.
The top institutional shareholder in the company is SB INVESTMENT ADVISERS (UK) LTD with over 16.68 million shares valued at $148.49 million. The investor’s holdings represent 12.2466% of the VIR Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 16.43 million shares valued at $146.26 million to account for 12.0632 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 12.85 million shares representing 9.4317% and valued at over $114.36 million, while STATE STREET CORP holds 3.7398 of the shares totaling 5.09 million with a market value of $45.34 million.
Vir Biotechnology Inc (VIR) Insider Activity
The most recent transaction is an insider sale by Napolitano Janet, the company’s Director. SEC filings show that Napolitano Janet sold 3,200 shares of the company’s common stock on Jun 02 ’25 at a price of $5.05 per share for a total of $16149.0. Following the sale, the insider now owns 16416.0 shares.
Still, SEC filings show that on Apr 03 ’25, De Backer Marianne (Chief Executive Officer) disposed off 79,712 shares at an average price of $5.95 for $0.47 million. The insider now directly holds 769,505 shares of Vir Biotechnology Inc (VIR).
